IVERIC bio, Inc. Quarterly Debt-to-equity in % from Q2 2014 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IVERIC bio, Inc. quarterly Debt-to-equity history and growth rate from Q2 2014 to Q1 2023.
  • IVERIC bio, Inc. Debt-to-equity for the quarter ending March 31, 2023 was 23.5 %, a 160% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 23.5 +14.5 +160% Mar 31, 2023
Q4 2022 17.7 +6.87 +63.7% Dec 31, 2022
Q3 2022 11.8 -0.97 -7.58% Sep 30, 2022
Q2 2022 7.95 -4.88 -38% Jun 30, 2022
Q1 2022 9.04 -0.49 -5.14% Mar 31, 2022
Q4 2021 10.8 +1.68 +18.4% Dec 31, 2021
Q3 2021 12.8 +4.5 +54.2% Sep 30, 2021
Q2 2021 12.8 +4.58 +55.5% Jun 30, 2021
Q1 2021 9.53 -1.44 -13.1% Mar 31, 2021
Q4 2020 9.11 -1.39 -13.2% Dec 31, 2020
Q3 2020 8.3 -2.09 -20.1% Sep 30, 2020
Q2 2020 8.25 -41.2 -83.3% Jun 30, 2020
Q1 2020 11 -101 -90.2% Mar 31, 2020
Q4 2019 10.5 -227 -95.6% Dec 31, 2019
Q3 2019 10.4 -597 -98.3% Sep 30, 2019
Q2 2019 49.5 -377 -88.4% Jun 30, 2019
Q1 2019 112 +2.07K Mar 31, 2019
Q4 2018 238 +740 Dec 31, 2018
Q3 2018 607 +986 Sep 30, 2018
Q2 2018 427 +792 Jun 30, 2018
Q1 2018 -1.96K -1.35K -220% Mar 31, 2018
Q4 2017 -502 +1.32K +72.4% Dec 31, 2017
Q3 2017 -379 -2.48K -118% Sep 30, 2017
Q2 2017 -365 -1.14K -147% Jun 30, 2017
Q1 2017 -613 -1.12K -222% Mar 31, 2017
Q4 2016 -1.82K -2.18K -600% Dec 31, 2016
Q3 2016 2.1K +1.79K +585% Sep 30, 2016
Q2 2016 772 +516 +201% Jun 30, 2016
Q1 2016 503 +265 +111% Mar 31, 2016
Q4 2015 364 +193 +112% Dec 31, 2015
Q3 2015 307 +191 +166% Sep 30, 2015
Q2 2015 257 +185 +257% Jun 30, 2015
Q1 2015 238 Mar 31, 2015
Q4 2014 171 Dec 31, 2014
Q3 2014 115 Sep 30, 2014
Q2 2014 71.8 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.